How Do Lung Cancer Patients Manage Skin Side Effects of Tarceva?
Tune in as Andrew Schorr and Carol Preston talk with lung cancer experts Dr. Scott Antonia and Dr. David Carbone about common side effects with Tarceva, also know as erlotinib. The doctors suggest two...
Author: P2Professional
Added: 08/24/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 25, 2015 Category: Cancer & Oncology Source Type: podcasts
How Do Lung Cancer Patients Manage Skin Side Effects of Tarceva?
Tune in as Andrew Schorr and Carol Preston talk with lung cancer experts Dr. Scott Antonia and Dr. David Carbone about common side effects with Tarceva, also know as erlotinib. The doctors suggest two...
Author: patientpower
Added: 08/24/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Adding to Tarceva in a Broad NSCLC Population: Weighing Benefits with Risks
A trial comparing Tarceva (erlotinib) to Cometriq (cabozantinib) showed modest benefit for EGFR wild type patients, but the challenging side effect profile should lead us to question if we can identif...
Author: cancergrace
Added: 07/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2015 Category: Cancer & Oncology Source Type: podcasts
Are EGFR TKIs (Such as Tarceva) Effective in Lung Cancer Patients Who Are Wild Type EGFR?
http://cancerGRACE.org/...
For patients with wild type EGFR, meaning there is no EGFR mutation, drugs like Tarceva (erlotinib) can have a small benefit, but Dr. Joan Schiller wants research to do bett...
Author: cancergrace
Added: 09/26/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 26, 2014 Category: Cancer & Oncology Source Type: podcasts
RADIANT and SELECT: Is Adjuvant Erlotinib Effective in Early-Stage Lung Cancer?
http://cancerGRACE.org/...
Drs. Nasser Hanna and Melissa Johnson discuss new trial evidence for the use of adjuvant Erlotinib for early-stage lung cancer.
GRACEcast 256 Lung
Author: cancergrace
Added: 08/06/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2014 Category: Cancer & Oncology Source Type: podcasts
What Went Wrong? Failure of MetMab with Tarceva in Advanced NSCLC
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
GRACEcast 244 Lung
Author: cancergrace
Added: 07/09/2014 (Source: Oncology Tube)
Source: Oncology Tube - July 9, 2014 Category: Cancer & Oncology Source Type: podcasts
Adding Avastin to Tarceva Help EGFR Positive Lung Cancer Patients?
http://cancerGRACE.org/...
Drs. Nasser Hanna, Melissa Johnson and Jack West discuss results of a phase 2 trial presented at ASCO 2014 that studied if adding Avastin (bevicizumab) to Tarceva helped EGF...
Author: cancergrace
Added: 06/16/2014 (Source: Oncology Tube)
Source: Oncology Tube - June 16, 2014 Category: Cancer & Oncology Source Type: podcasts
Dr. Rizvi on Nivolumab Plus Erlotinib in Patients with EGFR MT NSCLC
Naiyer A. Rizvi, MD, an associate attending physician, Memorial Sloan Kettering Cancer Center, discusses the safety and response with plus erlotinib in patients with epidermal growth factor receptor m...
Author: onclivetv
Added: 06/11/2014 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2014 Category: Cancer & Oncology Source Type: podcasts
Treating EGFR Patients After Tarceva Stops Working
http://cancerGRACE.org/...
Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center ...
Author: cancergrace
Added: 05/20/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 20, 2014 Category: Cancer & Oncology Source Type: podcasts
Erlotinib Prevent Disease Recurrence in Early Stage EGFR Positive NSCLC Patients?
http://cancerGRACE.org/...
Dr. Joel Neal of Stanford University Medical Center discusses the SELECT clinical trial which studied early stage non-small cell lung cancer patients and whether or not Tarc...
Author: cancergrace
Added: 05/20/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 20, 2014 Category: Cancer & Oncology Source Type: podcasts
Beyond erlotinib: Are second generation EGFR inhibitors better or simply newer?
Dr. Corey Langer chairs this 18th Annual "Perspectives in Thoracic Oncology" meeting which is captured in its entirety in this webcast. An expert faculty covers every aspect of lung cancer m...
Author: imedex
Added: 02/03/2014 (Source: Oncology Tube)
Source: Oncology Tube - February 3, 2014 Category: Cancer & Oncology Source Type: podcasts
MARQUEE Trial - Dr. Ron Burkes
Dr. Ron Burkes with commentary on Abstract #3410: A randomized, double-blind, placebo-controlled, phase 3 trial of tivantinib (ARQ 197) plus erlotinib versus placebo plus erlotinib in previously treat...
Author: oncologyeducation
Added: 10/07/2013 (Source: Oncology Tube)
Source: Oncology Tube - October 7, 2013 Category: Cancer & Oncology Source Type: podcasts
Can we predict which patients will benefit from Tarceva based on a blood test?
http://cancerGRACE.org/...
Drs. Mary Pinder, Nate Pennell, and Jack West review results from the PROSE trial presented at ASCO 2013, testing the predictive value of the Veristrat test of serum proteom...
Author: cancergrace
Added: 06/13/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 13, 2013 Category: Cancer & Oncology Source Type: podcasts
2013 OncPrac Summit: Corey Langer on managing NSCLC
Which lung cancer patients are eligible for bevacizumab therapy? What about maintenance therapy in this population? What's the latest on erlotinib therapy for EGFR-mutated patients? Find the answers t...
Author: feeds
Added: 04/22/2013 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2013 Category: Cancer & Oncology Source Type: podcasts
GRACEcast-116_Lung-Cancer_ASCO 2012 LC Highlights: Dr. Neal on SELECT Trial of Tarceva (Erlotinib)
http://cancerGRACE.org/...
Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resected EGFR mutation-positive early stage non-small cell...
Author: cancergrace
Added: 01/17/2013 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts
